ESMO Lifetime Achievement Award

The Dutch Cancer Institute (NKI) has won the ESMO Lifetime Achievement Award, presented by The European Society for Medical Oncology, for its `excellent translational research into breast cancer´.

Photo: ESMO Lifetime Achievement Award

The NKI has bridged the field of molecular biological research and the clinic. In particular it has developed genetic assays for breast cancer that, according to ESMO, lead to better understanding of the disease and probably to more precise and less aggressive treatment.
The ESMO award – which includes ?50,000 for research - was presented for the second time; last year it went to the Breast International Group (BIG), a platform for clinical research into breast cancer.

Apologies instead of condolences
The wife of a patient, who had been treated in the ICU of the Medisch Spectrum Twente Hospital after receiving serious burns during a barbecue accident, received a questionnaire asking her to tell the hospital management about her experience with condolences she had received. The hospital letter arrived just as her husband arrived home. Its opening sentence read: ‘Recently your husband died in the intensive care ward….’ The hospital offered its apologies … better than condolences!

31.08.2007

More on the subject:

Related articles

Photo

News • Rapid diagnostics

New system simultaneously detects antibiotic resistence and virulence of K. pneumoniae

Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.

Photo

News • Between the heart and the brain

Why cardiovascular disease and depression often develop together

Cardiovascular disease and depression do not co-occur by chance; the TO_AITION project aims to enable earlier diagnosis of comorbidity, better risk prediction and personalised treatment strategies.

Photo

News • When good bacteria fight back

Klebsiella strain to protect against IBD gut infections

New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).

Related products

Subscribe to Newsletter